A startup developing a one-time treatment that could rewind the clock on dying cells announced a major influx of funding. Life Biosciences, a startup co-founded by...
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. I’ve got a couple fun programming...
A San Diego biotech looking to double up on the power of antibody-drug conjugates with fewer toxicities has patched together a $137 million Series B from...
After Medline pulled off a massive $6.26 billion IPO late last year, the company now finds itself facing serious concerns being leveled by the FDA.
Insmed has given up on Brinsupri in the painful skin disorder hidradenitis suppurativa (HS) after a mid-stage trial failure. The company had ditched the pill in...
A new single‑cell sequencing method is giving researchers a clearer view of how immune cells actually behave—capturing not just what they plan to do, but what...
A year after the worst day of her life, Debra Miller received a voicemail she couldn’t quite make out. In a thick accent, a man said...
European VC Jeito gets $1.2B to help private biotechs control their 'destiny'
Post Content
Nature Biotechnology, Published online: 08 April 2026; doi:10.1038/s41587-026-03087-3 Sequence Display maps protein variant activities to a sequencing-based readout.
Scan to Read